#EGSCT2021 is off to a great start! Stephen Schoenberger’s symposium, “Exploring the Role of NeoAg-specific CD4+ T cells in Cancer Immunotherapy,” highlighted how neoantigens are advancing cancer therapeutics. Our ExPERT platform played an integral part. https://www.esgct.eu/

#ESGCT2021 is happening right now! Join us today to see for yourself how we’re enabling research and therapeutic development—whether it’s a visit to our virtual booth, downloading our posters or listening to a symposium talk, we’ve got you covered. https://www.esgct.eu/

ICYMI: MaxCyte rang the @Nasdaq closing bell last week. To watch the full video, click here: https://www.nasdaq.com/videos/maxcyte-inc.-rings-the-nasdaq-stock-market-closing-bell

#ClosingBell #NasdaqListed

Attending the 2021 #MDLSBioInnovation conference? Our President and CEO along with our Senior VP, Business Development are participating in the session, “Engineered Cell Therapies: Increasingly Complex Product Development.” Register today! http://ow.ly/9kZO50Gjuox

We’re a proud sponsor and participant of the 2021 Bio Innovation Conference. Learn more about #MDLSBioInnovation and register at http://ow.ly/l44f50GjtBS

Load More...

#EGSCT2021 is off to a great start! Stephen Schoenberger’s symposium, “Exploring the Role of NeoAg-specific CD4+ T cells in Cancer Immunotherapy,” highlighted how neoantigens are advancing cancer therapeutics. Our ExPERT platform played an integral part. https://t.co/jWnMkRfMPA https://t.co/WktEa9YhCT MaxCyte_info photo

#ESGCT2021 is happening right now! Join us today to see for yourself how we’re enabling research and therapeutic development—whether it’s a visit to our virtual booth, downloading our posters or listening to a symposium talk, we’ve got you covered. https://t.co/jWnMkRfMPA https://t.co/jyqUutDvfp MaxCyte_info photo

ICYMI: MaxCyte rang the @Nasdaq closing bell last week. To watch the full video, click here: https://t.co/WEu6PenNgj

#ClosingBell #NasdaqListed

Attending the 2021 #MDLSBioInnovation conference? Our President and CEO along with our Senior VP, Business Development are participating in the session, “Engineered Cell Therapies: Increasingly Complex Product Development.” Register today! https://t.co/2L87eSw9MD https://t.co/Uj3m2tDBn7 MaxCyte_info photo